Zhejiang New Donghai Pharmaceutical (Group) Co., Ltd

Zhejiang New Donghai Pharmaceutical (group) Co., Ltd

Category: Packaging, Printing & Paper > Paper & Paperboard

Country/Region: China

Main Products: Sulpiride, Levosulpiride, Pranlukast, 7-ADCA, (S)-N-ethyl-2-aminomethyl-pyrrolidine, N-ethyl-2-aminomethyl-pyrrolidine, Sulpiride

Company Introduction

Zhejiang New Donghai Pharmaceutical (Group) Co., Ltd was founded in 1981. Located in Zhedongnan chemical APIs import and export base in Taizhou city, New Donghai is a shareholding complex enterprise, with the production of pharmaceutical intermediates and APIs as main business. At present, our businesses cover production, research, trade and investment, etc.

Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2014, 2014

Legal Status: Own Lisence

Ownership: LLC

Employees: 501 - 1000 People

Factory Size: 3, 000-5, 000 square meters

R&D Team Size: Fewer than 5

Certifications: SA8000

Contact Information

Contact Person: Jessie Fang

Designation: Administrative

Department: Board Chairman/CEO

Telephone: 86-576-88827722

Business Information

Main Markets: United States (30%) Australia (23%) United Kingdom (20%) Canada (14%) Malaysia (12%) Chile (11%)

Export Focus: Australia, Canada, Chile, Malaysia, United Kingdom, United States

Contract Services: OEM Service Offered

Trade & Financial Information

Annual Revenue: More than 6 Million US Dollar

Registered Capital: US$1 Million - US$2.5 Million

Export Percentage: 71% - 80%

Payment Terms: Bank wire (T/T), Credit Card (CC), PayPal, Western Union (WU)

Product Showcase

•Sulpiride

•Levosulpiride

•Pranlukast

•7-ADCA

•(S)-N-ethyl-2-aminomethyl-pyrrolidine

•N-ethyl-2-aminomethyl-pyrrolidine

•Sulpiride

CL-Link > Packaging, Printing & Paper in China Paper & Paperboard in China